VanEck Biotech ETF (BBH)
147.94
-6.20 (-4.02%)
At close: Apr 04, 2025, 12:38 PM
-4.02% (1D)
| Bid | 147.69 |
| Market Cap | 370.95M |
| AUM | 449.01M |
| NAV | 175.63 |
| EPS (ttm) | 4.88 |
| PE Ratio (ttm) | 30.31 |
| Shares Out | 2.51M |
| Inception Date | Nov 23, 1999 |
| Ask | 148.4 |
| Volume | 11.97K |
| Open | 151.30 |
| Previous Close | 154.14 |
| Day's Range | 147.94 - 151.26 |
| 52-Week Range | 147.94 - 183.64 |
| Holdings | 27 |
| Expense Ratio | 0.35% |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol BBH
Inception Date Nov 23, 1999
Provider Vaneck
Website Fund Home Page
Top 10 Holdings 72.71% of assets
| Name | Symbol | Weight |
|---|---|---|
| Amgen Inc. | AMGN | 16.77% |
| Gilead Sciences, Inc... | GILD | 13.11% |
| Vertex Pharmaceutica... | VRTX | 11.51% |
| Regeneron Pharmaceut... | REGN | 5.33% |
| Argenx Se | ARGX | 5.28% |
| Natera, Inc. | NTRA | 4.69% |
| Iqvia Holdings Inc. | IQV | 4.53% |
| Alnylam Pharmaceutic... | ALNY | 4.53% |
| Icon Public Limited ... | ICLR | 3.57% |
| Biogen Inc. | BIIB | 3.39% |
Dividends Dividend Yield 0.79%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2024 | $1.2517 | Dec 24, 2024 |
| Dec 18, 2023 | $0.7127 | Dec 22, 2023 |
| Dec 19, 2022 | $0.7488 | Dec 23, 2022 |
| Dec 20, 2021 | $0.3972 | Dec 27, 2021 |
| Dec 21, 2020 | $0.6079 | Dec 28, 2020 |
